Vaccination pattern of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Hangzhou, China: a coverage and adverse events following immunization of different age groups

• Main Authors: Yan Liu (Author), Yuyang Xu (Author), Jun Wang (Author), Xinren Che (Author), Wenwen Gu (Author), Jian Du (Author), Xiaoping Zhang (Author), Xuechao Zhang (Author), Wei Jiang (Author), Junfang Chen (Author), Zhijie An (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been used to prevent pneumococcal disease, and PPSV23 became available in 2003 in Hangzhou, China as a private-sector, vaccinee-chosen vaccine. No national guidelines for PPSV23 have been developed. We analyzed PPSV23 coverage an...